AI assistant
MAGNITE, INC. — Director's Dealing 2021
Sep 11, 2021
31335_dirs_2021-09-10_ec992ae5-eb39-4192-9b6f-54751dfd6768.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MAGNITE, INC. (MGNI)
CIK: 0001595974
Period of Report: 2021-09-08
Reporting Person: Saltz Aaron (General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-08 | Common Stock | M | 5410 | $7.74 | Acquired | 263826 | Direct |
| 2021-09-08 | Common Stock | M | 28852 | $5.46 | Acquired | 292678 | Direct |
| 2021-09-10 | Common Stock | M | 965 | $5.28 | Acquired | 293643 | Direct |
| 2021-09-10 | Common Stock | M | 8264 | $3.61 | Acquired | 301907 | Direct |
| 2021-09-10 | Common Stock | M | 4575 | $5.16 | Acquired | 306482 | Direct |
| 2021-09-10 | Common Stock | S | 40004 | $30.21 | Disposed | 266478 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-08 | Stock Option (Right to Buy) | $7.74 | M | 5410 | Disposed | 2023-07-31 | Common Stock (5410) | Direct |
| 2021-09-08 | Stock Option (Right to Buy) | $5.46 | M | 28852 | Disposed | 2023-03-05 | Common Stock (28852) | Direct |
| 2021-09-10 | Stock Option (Right to Buy) | $5.28 | M | 965 | Disposed | 2030-04-01 | Common Stock (965) | Direct |
| 2021-09-10 | Stock Option (Right to Buy) | $3.61 | M | 8264 | Disposed | 2028-02-27 | Common Stock (8264) | Direct |
| 2021-09-10 | Stock Option (Right to Buy) | $5.16 | M | 4575 | Disposed | 2029-02-28 | Common Stock (4575) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.15 to $30.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: This option is fully vested and immediately exercisable.
F3: Equity grant under the Company's 2014 Equity Incentive Plan.
F4: 25% of the total number of shares underlying this option vested on April 1, 2021 and the remaining shares vest 1/36 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date. This equity grant may be subject to accelerated vesting in the event the Reporting Person's employment is terminated under certain circumstances.
F5: 25% of the total number of shares underlying this option vested on February 14, 2019 and the remaining shares vest 1/36 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date. This equity grant may be subject to accelerated vesting in the event the Reporting Person's employment is terminated under certain circumstances.
F6: 25% of the total number of shares underlying this option vested on February 14, 2020 and the remaining shares vest 1/36 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date. This equity grant may be subject to accelerated vesting in the event the Reporting Person's employment is terminated under certain circumstances.